L'OCCITANE (00973.HK) -0.150 (-0.451%) Short selling $8.28K; Ratio 0.028% 's FY2024 revenue growth was in line with expectations, UBS released a research report saying.
Operating margin excluding exceptional impact of impairments and share of profits or losses of associates was also in line with expectations. Therefore, UBS rated the Group at Neutral, with a target price of $30.6.
Related NewsCiti Hikes L'OCCITANE (00973.HK) TP to $34; Annual COP In Line
L'OCCITANE's management expects low teen sales growth and a 1 ppt improvement in operating margins in FY2025, according to the report. In terms of medium term guidance, sales are forecasted to grow at a CAGR of 12-14%, and operating margin is expected to recover to nearly 15% by FY2027.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-06-24 16:25.)
AAStocks Financial News
China's assets explosion and the high record global capital influx hit
Hong Kong Stocks Surge, Hang Seng Index Opens Up 543 Points
China's bailout policy triggers LVMH and Hermès to rise nearly 10%
Will policies boost confidence and the A-share market live up to expectations?
Check whenever you want
WikiStock APP